Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Assets Average (2016 - 2025)

Historic Assets Average for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $64.3 million.

  • iBio's Assets Average rose 17815.81% to $64.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $64.3 million, marking a year-over-year increase of 17815.81%. This contributed to the annual value of $26.0 million for FY2025, which is 2576.74% down from last year.
  • As of Q4 2025, iBio's Assets Average stood at $64.3 million, which was up 17815.81% from $43.7 million recorded in Q3 2025.
  • Over the past 5 years, iBio's Assets Average peaked at $145.4 million during Q3 2021, and registered a low of $20.4 million during Q1 2025.
  • In the last 5 years, iBio's Assets Average had a median value of $45.9 million in 2023 and averaged $70.2 million.
  • Per our database at Business Quant, iBio's Assets Average skyrocketed by 26652.46% in 2021 and then plummeted by 6022.38% in 2023.
  • iBio's Assets Average (Quarter) stood at $135.1 million in 2021, then plummeted by 49.53% to $68.2 million in 2022, then tumbled by 47.42% to $35.8 million in 2023, then plummeted by 35.55% to $23.1 million in 2024, then surged by 178.16% to $64.3 million in 2025.
  • Its Assets Average stands at $64.3 million for Q4 2025, versus $43.7 million for Q3 2025 and $21.1 million for Q2 2025.